Status:
UNKNOWN
Treatment of Juvenile Recurrent Parotitis: the Yield of Minimally Invasive Intervention
Lead Sponsor:
Carmel Medical Center
Conditions:
Parotitis, Juvenile Recurrent
Eligibility:
All Genders
3-18 years
Phase:
NA
Brief Summary
Juvenile recurrent parotitis (JRP) is an inflammatory disease characterized by recurrent painful swelling of the Parotid gland in the pediatric age. A watchful waiting treatment strategy was acceptabl...
Detailed Description
Juvenile recurrent parotitis (JRP) is an inflammatory disease characterized by recurrent painful swelling of the Parotid gland in the pediatric age. A watchful waiting treatment strategy was acceptabl...
Eligibility Criteria
Inclusion
- age 3-18 y/o at least 2 documented incidents in at least 12 months period
Exclusion
- previous parotis interventions e.g. sialography/sialendoscopy/parotidectomy parotitis due to any other known cause (e.g. bacterial infection, autoimmune disease etc.)
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04074694
Start Date
January 1 2020
End Date
January 1 2023
Last Update
August 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Otolaryngology, Carmel Medical Center
Haifa, Israel, 34362